JOJi-Eun Oh

Ji-Eun Oh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ji-Eun Oh has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Estrogen receptor expression in GnRH neurons: back to the future

    by Ji-Eun Oh, Haoyun Li, Mary Bunnell, Ashley Chan, Anastasiia Vasetska, Sungsik Park, Lea Stangenes, PoChing Lin, Kun Wang, CheMyong Ko

    Estrogen feedback within the hypothalamic–pituitary–gonadal axis is mediated primarily by upstream estrogen-sensitive neuronal populations, most notably kisspeptin neurons, which translate circulating sex steroid levels into excitatory or inhibitory input to gonadotropin-releasing hormone (GnRH) neurons, the final neural output controlling pituitary gonadotropin secretion. Despite extensive research, the expression and role of estrogen receptors in GnRH neurons remain poorly understood. To systematically evaluate what can be inferred from transcriptomic data alone, we conducted a comprehensive analysis of open-source single-cell and single-nucleus RNA-sequencing (sc/snRNA-seq) datasets encompassing mouse embryogenesis through adulthood, supplemented by cross-species datasets from rat, squirrel, pig, and human hypothalami. In adult mice, Esr1 transcripts were detected in a distinct subset of Gnrh1+ cells more frequently than Esr2 transcripts. Notably, this expression was dynamic, with an increased proportion of Esr1+Gnrh1+ cells emerging during maturation, particularly after puberty. In contrast, Esr2 detection remained minimal across developmental stages. Pseudotime analysis showed Esr1+Gnrh1+ cells at late pseudotime, coinciding with advanced maturation states. Cross-species comparisons further revealed species-specific patterns, with Esr1+Gnrh1+ cells consistently more prevalent than Esr2+Gnrh1+ cells in rodents, while ESR2+GNRH1+ cells were slightly more detectable in pigs and humans. These results support a model where estrogen signaling within GnRH neurons is heterogeneous, developmentally regulated, and often mediated indirectly through upstream estrogen-sensitive circuits, such as kisspeptin and nitric oxide synthase neurons. This study provides a comprehensive, unbiased transcriptomic framework for understanding estrogen receptor expression in GnRH neurons, offering new insights into how estrogen might influence reproductive function through both direct and indirect signaling pathways.

  • A Dynamic Shift in Estrogen Receptor Expression During Granulosa Cell Differentiation in the Ovary

    by Chan Jin Park, Ji-Eun Oh, PoChing Lin, Sherry Zhou, Mary Bunnell, Emmanuel Bikorimana, Michael J Spinella, Hyunjung Jade Lim, CheMyong J Ko

    This study uncovers a dynamic shift in estrogen receptor expression during granulosa cell (GC) differentiation in the ovary, highlighting a transition from estrogen receptor alpha (ESR1) to estrogen receptor beta (ESR2). Using a transgenic mouse model with Esr1-iCre-mediated Esr2 deletion, we demonstrate that ESR2 expression is absent in GCs derived from ESR1-expressing ovarian surface epithelium (OSE) cells. Single-cell analysis of the OSE-GC lineage reveals a developmental trajectory from Esr1-expressing OSE cells to Foxl2-expressing pre-GCs, culminating in GCs exclusively expressing Esr2. Transcriptome analyses identified vasculature-derived TGFβ1 ligands as key regulators of this transition. Supporting this, TGFβ1 treatment of cultured embryonic ovaries reduced Esr1 expression while promoting Esr2 expression. This study underscores the capability of GCs to switch from ESR1 to ESR2 expression as a fundamental aspect of normal differentiation.


  • Open Access

    Inhibition of testicular development by suppressing neonatal LH rise in male domestic pigs

    by ChanJin Park, Sandra Soto-Heras, Lindsey Reinacher, Katie Chai, Sherry Zhou, Po-Ching Lin, Ji-Eun Oh, Mary Bunnell, Rex A. Hess, Luiz Renato de França, et al.


  • Open Access

    Repopulation of autophagy-deficient stromal cells with autophagy-intact cells after repeated breeding in uterine mesenchyme-specific Atg7 knockout mice

    by Ji-Eun Oh, Sojung Kwon, Hyunji Byun, Haengseok Song, Hyunjung Jade Lim

    Objective: Autophagy is highly active in ovariectomized mice experiencing hormone deprivation, especially in the uterine mesenchyme. Autophagy is responsible for the turnover of vasoactive factors in the uterus, which was demonstrated in anti-Müllerian hormone receptor type 2 receptor (Amhr2)-Cre-driven autophagy-related gene 7 (Atg7) knockout (Amhr-Cre/Atg7f/f mice). In that study, we uncovered a striking difference in the amount of sequestosome 1 (SQSTM1) accumulation between virgin mice and breeder mice with the same genotype. Herein, we aimed to determine whether repeated breeding changed the composition of mesenchymal cell populations in the uterine stroma.Methods: All female mice used in this study were of the same genotype. Atg7 was deleted by Amhr2 promoter-driven Cre recombinase in the uterine stroma and myometrium, except for a triangular stromal region on the mesometrial side. Amhr-Cre/Atg7f/f female mice were divided into two groups: virgin mice with no mating history and aged between 11 and 12 months, and breeder mice with at least 6-month breeding cycles with multiple pregnancies and aged around 12 months. The uteri were used for Western blotting and immunofluorescence staining. Results: SQSTM1 accumulation, representing Atg7 deletion and halted autophagy, was much higher in virgin mice than in breeders. Breeders showed reduced accumulation of several vasoconstrictive factors, which are potential autophagy targets, in the uterus, suggesting that the uterine stroma was repopulated with autophagy-intact cells during repeated pregnancies. Conclusion: Multiple pregnancies seem to have improved the uterine environment by replacing autophagy-deficient cells with autophagy-intact cells, providing evidence of cell mixing.


  • Open Access

    Lifetime changes of the oocyte pool: Contributing factors with a focus on ovulatory inflammation

    by Chan Jin Park, Ji-Eun Oh, Jianan Feng, Yoon Min Cho, Huanyu Qiao, CheMyong Ko

    In mammalian species, females are born with a number of oocytes exceeding what they release via ovulation. In humans, an average girl is born with over a thousand times more oocytes than she will ovulate in her lifetime. The reason for having such an excessive number of oocytes in a neonatal female ovary is currently unknown. However, it is well established that the oocyte number decreases throughout the entire lifetime until the ovary loses them all. In this review, data published in the past 80 years were used to assess the current knowledge regarding the changing number of oocytes in humans and mice, as well as the reported factors that contribute to the decline of oocyte numbers. Briefly, a collective estimation indicates that an average girl is born with approximately 600,000 oocytes, which is 2,000 times more than the number of oocytes that she will ovulate in her lifetime. The oocyte number begins to decrease immediately after birth and is reduced to half of the initial number by puberty and almost zero by age 50 years. Multiple factors that are either intrinsic or extrinsic to the ovary contribute to the decline of the oocyte number. The inflammation caused by the ovulatory luteinizing hormone surge is discussed as a potential contributing factor to the decline of the oocyte pool during the reproductive lifespan.


  • Abstract 1291: Tumor growth inhibitory effect in EIF4B silenced in vitro and in vivo lung cancer models

    by Jung-Young Shin, Xiang-Hua Zhang, Jeong-Oh Kim, Ji-Eun Oh, Hiun Suk Chae, Young Ae Joe, Jin-Hyoung Kang

    Backgraound The eIF4B, a key molecule for initiation of protein translation, play an important role in cell growth, proliferation and survival. We investigated that eIF4B is associated with the molecular mechanism of de novo resistance against EGFR TKIs and its role on cell proliferation and survival in NSCLC cells. Method Among five NSCLC cell lines harboring EGFR and K-RAS wild type, PC14 cells showing the highest IC50, were selected for our experiment. In eIF4B silenced PC14 cells by shRNA, we evaluated cell proliferation by direct cell counts and SRB assay and cell cycle distribution using flow cytometry. The expression of signal molecules, transcription factors and apoptosis associated proteins was measured by Western blot. In vivo tumor model established by subcutaneous injection of eIF4B silenced PC14 cells, the retardation of tumor growth was measured. Results In PC14 cells transformed with eIF4B shRNA, we observed the protein expression of eIF4B was reduced (>70% at day 5). The proliferation of eIF4B silenced cells was greatly inhibited both in vitro and in vivo tumor model. Between eIF4B silenced cells and control cells, there was no significant difference in anti-proliferative activity of several target inhibitors (enzastaurin, gefitinib, LY294002, vandetanib) against EGFR-PI3K-AKT signaling molecules. The expression of proteins involved in cell survival (pEGFR, pAKT and mTOR), transcription factors (pNFkB and TS) and anti-apoptotic protein (bcl-2), was decreased and apoptosis associated proteins (phospho-p53 and active caspase-3) were increased. The G0/G1 cell fraction in eIF4B silenced cells was reduced (47.3% vs. 55.1% in control cells) and accumulation of apoptotic cells was observed (12.7% vs. 1.5% in control cells; shown as sub G1 population). Conclusion Our results demonstrated that eIF4B silencing resulted in a marked decrease of several anti-apoptotic and pro-proliferative proteins and eIF4B was required for cell proliferation and survival by regulating cell cycle and cell signaling molecules. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1291. doi:1538-7445.AM2012-1291